Please find below the link to a recently published article in the New England Journal of Medicine “MDR Tuberculosis — Critical Steps for Prevention and Control” by Eva Nathanson, Paul Nunn, Mukund Uplekar, Katherine Floyd, Ernesto Jaramillo, Knut Lönnroth, Diana Weil and Mario Raviglione. The authors present an excellent overview to critical gaps in MDR-TB prevention and control and discuss measures to address them.
The WHO member states have committed at the World Health Assembly, May 2009, to achieve universal access to diagnosis and treatment of MDR-TB by year 2015. Achieving this goal is a major undertaking, both for Member States but also for all members of the Stop TB community.
Based on your experience, what are the major gaps in reaching universal access to diagnosis and treatment of drug resistant TB and providing care for patients? What are the steps your country or community taking in addressing these barriers?
It would be very useful to hear your views